Growing initiatives by government for promoting immunization is fueling the growth of cell culture media for the vaccine market

 

cell culture media for the vaccine market

Cell culture media for vaccine is a media that is composed of amino acids, inorganic salts, vitamins, serum, glucose, etc. They are used to develop vaccines and other therapies for treating a wide range of life-threatening disease

The high prevalence of infectious disease is a key factor driving the growth of the cell culture media for vaccine. According to the World Health Organization, nearly 50,000 men, women, and children are dying every day from infectious diseases. Growing initiatives and approval by the government coupled with the rising research and development activities for developing effective vaccines is also projected to foster the growth of the cell culture media for vaccine market. Increasing initiatives by organization and government for promoting immunization around the globe is again estimated to propel the growth of the market. Moreover, a growing number of vaccine clinical trials around the globe is further projected to propel the growth of the market. Furthermore, the increasing availability of novel blood plasma derivatives is further anticipated to propel the growth of the market over the forecast period.

North America is projected to gain significant growth over the forecast period and this is attributed to the increasing investment in the research and development activities by the pharmaceutical and biotechnology industry in the region. According to the Pharmaceutical Research and Manufacturers of America, The entire biopharmaceutical industry invested an estimated $102 billion in research and development (R&D) in 2018. PhRMA members invested $83 billion in R&D in 2019, establishing the biopharmaceutical sector as the most R&D-intensive industry in the U.S. economy.

Key Developments:

1.     1. In October 2019, Thermo Fisher Scientific launched Cell Culture Media as First to Remain Stable When Stored at Room Temperature. Gibco BenchStable Media is the latest offering in the Gibco product line from Thermo Fisher Scientific and provides a flexible alternative for biological researchers that also saves energy.

2.   2.   In May 2019, Sartorius Stedim Biotech (SSB) has introduced its new generation of Ambr® 15 Cell Culture automated microbioreactor system. This media reduce cell line development timelines and increase lab productivity.

3.    3.  In November 2019, Thermo Fisher Scientific has invested nearly $24 million in its biologics site at Inchinnan, Scotland, to boost its ability to manufacture cell culture media.

4.    4. In March 2020, Lonza has launched a new medium the TheraPEAK™ SfAAV™ Medium is specifically designed to support the development of safe, scalable, life-saving gene therapies


Comments

Popular posts from this blog

Fitness Equipment Market is doing warm-ups to pull growth-rich opportunities from the growing obesity rates accompanied by the sedentary lifestyles

The market for ureteral stents would benefit from the rising prevalence of urological diseases

The North America Vision Care Market Is Driven by the Increasing Prevalence of Eye Diseases in this Region